Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
29.56B | 30.16B | 30.91B | 31.91B | 33.80B | 33.38B | Gross Profit |
2.87B | 2.46B | 3.17B | 3.25B | 4.06B | 3.78B | EBIT |
675.00M | 226.00M | 994.00M | 1.01B | 1.82B | 1.60B | EBITDA |
1.01B | 825.00M | 1.54B | 1.48B | 1.48B | 2.46B | Net Income Common Stockholders |
407.00M | 167.00M | 587.00M | 630.00M | 1.19B | 1.19B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.38B | 7.03B | 11.18B | 10.71B | 10.68B | 9.27B | Total Assets |
24.49B | 24.55B | 27.69B | 28.16B | 27.55B | 27.11B | Total Debt |
0.00 | 34.00M | 33.00M | 25.00M | 25.00M | 38.00M | Net Debt |
-6.38B | -6.99B | -11.14B | -10.69B | -10.65B | -9.23B | Total Liabilities |
11.09B | 10.99B | 14.04B | 14.81B | 15.01B | 15.45B | Stockholders Equity |
13.40B | 13.56B | 13.65B | 13.36B | 12.54B | 11.52B |
Cash Flow | Free Cash Flow | ||||
0.00 | -3.55B | 831.00M | 1.35B | 1.70B | 561.00M | Operating Cash Flow |
0.00 | -3.15B | 1.82B | 2.14B | 2.43B | 1.10B | Investing Cash Flow |
0.00 | -600.00M | -1.00B | -793.00M | -752.00M | -520.00M | Financing Cash Flow |
0.00 | -402.00M | -351.00M | -297.00M | -267.00M | -250.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥108.25B | 17.50 | 2.38% | 2.35% | 25.15% | ||
77 Outperform | ¥74.39B | 16.66 | 6.06% | 7.21% | 11.23% | ||
75 Outperform | ¥51.97B | 13.58 | 6.23% | 12.86% | 41.67% | ||
74 Outperform | ¥138.15B | 16.61 | 7.89% | -7.59% | 18.77% | ||
66 Neutral | ¥41.03B | 8.03 | 4.15% | -1.39% | 16.32% | ||
66 Neutral | $4.47B | 12.21 | 5.40% | 3.65% | 4.14% | -12.00% | |
61 Neutral | ¥13.02B | 78.46 | 2.81% | -2.45% | -71.57% |